Yonika Arum Larasati

Curcumin targets multiple enzymes involved in the ROS metabolic pathway to suppress tumor cell growth

Yonika Arum Larasati, Noriko Yoneda‐Kato, Ikuko Nakamae et al. · Scientific Reports · 2018 · 206 citations · Full text

Medicine, Oncology, Pharmacology +17

Anti-proliferative and Anti-metastatic Potential of Curcumin Analogue, Pentagamavunon-1 (PGV-1), Toward Highly Metastatic Breast Cancer Cells in Correlation with ROS Generation

Edy Meiyanto, Herwandhani Putri, Yonika Arum Larasati et al. · Advanced Pharmaceutical Bulletin · 2019 · 61 citations · Full text

Medicine, Oncology, Pharmacology +16

Restoration of the GTPase activity and cellular interactions of Gα _o mutants by Zn ²⁺ in <i>GNAO1</i> encephalopathy models

Yonika Arum Larasati, Mikhail Savitsky, Alexey Koval et al. · Science Advances · 2022 · 48 citations · Full text

Life Sciences, Neurobiology, Neuroscience +14

The Target Differences of Anti-Tumorigenesis Potential of Curcumin and its Analogues Against HER-2 Positive and Triple-Negative Breast Cancer Cells

Edy Meiyanto, Ulfatul Husnaa, Ria Fajarwati Kastian et al. · Advanced Pharmaceutical Bulletin · 2020 · 35 citations · Full text

Medicine, Oncology, Pharmacology +17

Cardioprotective and hepatoprotective effects of Citrus hystrix peels extract on rats model

Herwandhani Putri, Standie Nagadi, Yonika Arum Larasati et al. · Asian Pacific Journal of Tropical Biomedicine · 2013 · 34 citations · Full text

Pharmacy, Pharmacology, Toxicology +14